This present report is the first to document poor HCT outcomes for CGD patients harboring non-CYBB gene mutations, whereas previous studies had noted that non-CYBB gene mutations were associated with better HCT outcome than CYBB mutations (4, 5, 15). The gene discussed is CYBB; the disease is chronic granulomatous disease.